市场调查报告书
商品编码
1603759
农业基因工程的全球市场预测(~2030 年):按技术、应用、最终用户和区域进行分析Genetic Engineering in Agriculture Market Forecasts to 2030 - Global Analysis By Technique, Application, End User and by Geography |
根据Stratistics MRC预测,2024年全球基因工程在农业市场规模将达10.9亿美元,预测期内复合年增长率为8.5%,预计2030年将达到17.7亿美元。农业基因工程涉及修改农作物和牲畜的 DNA,以增强产量、抗虫性、耐旱性和营养等特定性状。生物技术的发展使科学家能够将有利的基因直接引入植物和动物中,从而实现传统育种难以实现的精确改良。此外,抗虫玉米和耐除草剂大豆是基因工程(GE)作物的两个例子,它们在世界范围内得到了广泛接受,因为它们可以在减少化学投入的同时提高产量。
根据联合国粮食及农业组织 (FAO) 统计,2022 年全球基因改造 (GE)作物面积约 1.9 亿公顷。
引进基改作物(GMO)
由于其众多的好处,基因改造作物的采用率正在稳步上升。基因改造作物对农民很有吸引力,因为它们通常需要较少的投入,例如肥料和水,并且对病虫害具有更强的抵抗力。它不仅提高了农民的盈利,而且还透过减少化学品的使用量来减少对环境的影响。基因改造作物现在在法律规范较为宽鬆的地区(例如北美)的农业实践中很常见。此外,随着消费者越来越意识到基改作物的好处,例如增加营养价值和减少食品废弃物,公众舆论也逐渐转变,这将鼓励更广泛的采用。
社会和道德问题
基因工程提出了关于「神化」自然和为了人类的利益而改变生物体是否适当的伦理问题。基因改造因损害自然过程并可能产生意想不到的后果而受到批评。大型生技公司对种子专利的垄断进一步引发了社会担忧,因为这可能会限制农民以后保存和使用收穫种子的能力。此外,这种方法可能导緻小农依赖种子公司进行年度采购,引发人们对种子取得和经济公平的担忧。
作物新品种开发
基因工程市场充满了创造适合特定消费者偏好和当地要求的创新作物品种的机会。例如,可以对作物进行改良,使其具有更好的味道和质地,或具有更长的保质期,从而提高适销性并减少整个供应链中的食品废弃物。也有潜力开拓满足专业市场和新消费趋势的特种作物,例如无麸质和有机产品。
公共卫生问题
对基因改造食品的接受仍然受到公共卫生问题的严重威胁。儘管科学界对基因改造食品的安全性已达成共识,但一些消费者仍担心食用基因改造食品可能产生毒性和过敏。有关不良健康影响的报告要求对基因改造产品进行更彻底的测试和标籤。此外,相关人员很难有效传达基因改造的好处。这是因为假讯息宣传活动和不利的媒体报导加剧了这些恐惧。
COVID-19 大流行扰乱了供应链和劳动力供应、降低了作物产量并导致研发延误,对农业基因工程市场产生了重大影响。进出口限制限制了获得关键生物技术工具和资源的机会,而封锁造成了农业劳动力短缺,并扰乱了种植和收割作业。此外,这场大流行提高了人们对粮食安全问题的认识,并增加了对生物技术解决方案的兴趣。然而,随着该行业寻求从这些挫折中恢復过来,农民的经济负担和农业创新投资的减少可能会对市场扩张构成长期障碍。
DNA 和 RNA 定序领域预计在预测期内规模最大
预计最大份额出现在 DNA/RNA 序列片段中。这部分至关重要,因为它透过精确的遗传分析和修改在提高农业生产力方面发挥关键作用。透过 DNA 和 RNA定序技术鑑定与所需性状相关的遗传标记,有助于开发具有更高产量、抗病性和营养价值的基因改造作物。此外,作物改良越来越依赖基因工程技术和分子标记,这不仅有利于育种,而且有助于了解植物基因组,这也强调了这一领域的重要性。
水果和蔬菜领域预计在预测期内复合年增长率最高
水果和蔬菜领域预计将呈现最高的复合年增长率。这种增长主要是由于对健康和食品的需求不断增加食品消费者对水果和蔬菜营养价值的认识不断提高。随着越来越多的消费者更加重视健康的饮食习惯,迫切需要开发更美味、更长保质期、更有营养的改良品种。此外,支持该市场成长的是都市区园艺和当地食品生产的日益普及,基因改造蔬菜和水果成为寻求健康、新鲜农产品的消费者的特色,因为它可以满足您的需求。
北美在农业基因工程方面占据最大的市场占有率。这项优势的主要原因是美国和加拿大等国家拥有发达的农业基础设施、强大的研发能力以及对基因改造生物(GMO)的支持性法规结构。对基因工程技术的大规模投资提高了作物产量、提高了害虫抗性并减少了对化学投入的依赖,使北美处于农业生物技术采用的前沿。此外,该地区成熟的生物技术部门以及农民和消费者对基因改造作物的高接受度进一步加强了该地区的市场主导地位。
农业基因工程市场预计将以亚太地区最高的复合年增长率成长。人口的快速增长、粮食需求的增加以及扩大使用尖端分子生物学和遗传学技术来提高作物产量和生产力是推动这一增长的因素。中国和印度等国家处于领先地位,它们正在大力投资生物技术研发,以解决土壤劣化和气候变迁等农业问题。此外,重要生物技术公司的存在以及政府对农业创新的持续支持进一步支持了该领域的市场成长。
According to Stratistics MRC, the Global Genetic Engineering in Agriculture Market is accounted for $1.09 billion in 2024 and is expected to reach $1.77 billion by 2030 growing at a CAGR of 8.5% during the forecast period. Genetic engineering in agriculture involves modifying the DNA of crops and livestock to enhance specific traits, such as yield, pest resistance, drought tolerance, and nutritional content. Scientists can now directly introduce advantageous genes into plants or animals thanks to this biotechnological development, making precise improvements that would be difficult to accomplish through conventional breeding. Moreover, insect-resistant corn and herbicide-tolerant soybeans are two examples of genetically engineered (GE) crops that have gained widespread acceptance around the world because of their capacity to boost output while lowering the demand for chemical inputs, thereby encouraging more sustainable farming methods.
According to the Food and Agriculture Organization (FAO), genetically engineered (GE) crops covered approximately 190 million hectares globally in 2022.
Genetically modified organism (GMO) adoption
The adoption rate of GMOs has been steadily increasing due to their numerous benefits. Genetically modified crops appeal to farmers because they frequently require fewer inputs, like fertilizer and water, while offering greater resistance to pests and diseases. In addition to making farmers more profitable, this also helps to lessen the impact on the environment by using fewer chemicals. GMOs are now commonplace in agricultural practices in areas with more benevolent regulatory frameworks, such as North America. Furthermore, there is a slow change in public opinion that encourages broader adoption as consumer awareness of the advantages of GMOs, such as increased nutritional value and decreased food waste, increases.
Social and ethical concerns
Genetic engineering raises ethical questions about "playing God" with nature and the propriety of modifying living things for the sake of humanity. Genetic modification is criticized for undermining natural processes and potentially having unintended consequences. Large Biotech Company's monopolization of seed patents raises additional societal concerns because it may restrict farmer's ability to save seeds from their harvests for later use. Moreover, this approach may lead to smallholder farmers becoming dependent on seed companies for yearly purchases, which raises concerns about access and economic equity.
Development of novel crop varieties
The market for genetic engineering offers a wealth of chances to create innovative crop varieties suited to particular consumer preferences or regional requirements. For instance, it is possible to engineer crops to have better taste and texture or longer shelf lives, which will increase their marketability and decrease food waste across the supply chain. Additionally, there is also the possibility of developing specialty crops that serve specialized markets or new consumer trends, like gluten-free or organic products.
Issues with public health
Genetically modified food acceptance is still seriously threatened by public health concerns. Notwithstanding the scientific consensus regarding the safety of genetically modified foods, some consumers are concerned about the possibility of toxicity or allergies when consuming GMOs. Reports of negative health effects have prompted demands for more thorough testing and labeling of genetically modified products. Furthermore, it is also difficult for stakeholders to effectively convey the advantages of genetic engineering because of disinformation campaigns and unfavorable media representations that heighten these anxieties.
The COVID-19 pandemic had a major effect on the market for genetic engineering in agriculture by interfering with supply chains and labor availability, which decreased crop yields and caused delays in R&D. While import and export restrictions restricted access to vital biotechnology tools and resources, lockdowns caused a shortage of agricultural workers, which hampered planting and harvesting operations. Moreover, the pandemic raised awareness of food security concerns and sparked a surge in interest in biotechnology solutions; nevertheless, the financial burden on farmers and decreased investment in agricultural innovation may present long-term obstacles to market expansion as the sector attempts to bounce back from these setbacks.
The DNA & RNA Sequencing segment is expected to be the largest during the forecast period
The largest share is expected to be held by the DNA & RNA sequencing segment. Because it plays a crucial part in increasing agricultural productivity through accurate genetic analysis and modification, this segment is essential. The development of genetically modified crops with increased yields, disease resistance, and nutritional value is made easier by the identification of genetic markers linked to desired traits made possible by DNA and RNA sequencing technologies. Additionally, the importance of the segment is highlighted by the growing reliance on transgenic technology and molecular markers for crop improvement, which not only facilitates breeding but also helps understand plant genomes.
The Fruits & Vegetables segment is expected to have the highest CAGR during the forecast period
The fruits and vegetables segment is projected to exhibit the highest CAGR. This growth is mostly due to rising demand for health and wellness foods as well as growing consumer awareness of the nutritional advantages of fruits and vegetables. It is imperative to develop improved varieties with better taste, longer shelf life, and higher nutritional value as more consumers place a higher priority on eating a healthy diet. Furthermore, supporting the growth of this market is the growing popularity of urban gardening and local food production, as genetically modified fruits and vegetables can satisfy the particular needs of consumers looking for wholesome, fresh produce.
The North American region holds the largest market share for genetic engineering in agriculture. The main reasons for this dominance are the developed agricultural infrastructure, robust R&D capacities, and supportive regulatory framework for genetically modified organisms (GMOs) in nations such as the US and Canada. With large investments in genetic engineering technologies that increase crop yields, improve pest resistance, and lessen dependency on chemical inputs, North America has been at the forefront of the adoption of agricultural biotechnology. Moreover, the region's dominant position in the market is further cemented by its well-established biotech sector and the high rate of farmer and consumer acceptance of GM crops.
The market for genetic engineering in agriculture is anticipated to grow at the highest CAGR in the Asia-Pacific region. Rapid population growth, which raises food demand, and the growing use of cutting-edge molecular biology and genetics technologies to increase crop yield and productivity are some of the factors contributing to this growth. Leading the way in this trend are nations like China and India, which have made significant investments in biotechnology research and development to tackle issues in agriculture like soil degradation and climate variability. Additionally, the market's growth in this area is further supported by the existence of significant biotechnology firms and continuous government assistance for agricultural innovation.
Key players in the market
Some of the key players in Genetic Engineering in Agriculture market include Agilent Technologies, Illumina, Inc., Eurofins Scientific, Qiagen N.V., Neogen Corporation, Traitgenetics GmbH, Keygene, Synthego Corporation, Oxford Nanopore Technologies, Novogene Corporation, GenScript, Trace Genomics, Intellia Therapeutics and NRgene.
In October 2024, Eurofins Scientific, a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro diagnostic products, has reached an agreement with SYNLAB to acquire its clinical diagnostics operations in Spain. The transaction is subject to customary conditions, including regulatory approvals, and is expected to close in 2025.
In August 2024, Illumina Inc, a major biotech firm in DNA sequencing and array-based technologies, on Friday announced the setting up of a Global Capability Center in Bengaluru. The centre would be an investment to expand its technology workforce in support of a global customer base.
In July 2024, Agilent Technologies Inc. has signed a definitive agreement to acquire BIOVECTRA, a specialized contract development and manufacturing organization (CDMO), for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.